|Last Price||Today's Change||52-Week Range||Trading Volume|
|32.79||-0.08 (-0.24%)||28.47 - 36.46||16.1 million (Below Avg)|
Market data as of 1:00PM 11/27/15. Quotes are delayed by at least 15 min.
Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products
11/25/2015 4:00 AM ET